StreetAlpha.app
Home › Stocks › SYK

Stryker Corp (SYK)

Healthcare
$310.00
▼ −0.98%
LAST CLOSE · NOV 20

Stryker makes surgical, orthopaedic and emergency medical products sold mainly to doctors and hospitals. It last closed at $310.00 on Nov 20, down 0.98% on the day. The next earnings report for SYK is expected around Thu, Jan 28, 2027, after the close. For the quarter ended Sep 2026, SYK reported EPS of $1.96 on revenue of $6.52B, with revenue up 7.6% from a year ago. Over its last 8 reports the stock moved an average of 4.1% the session after earnings. Over the last 12 months SYK insiders bought $0 of stock on the open market and sold $579.7M, according to SEC Form 4 filings.

AI Auto Pilots
Is SYK in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold SYK.

Key Stats

Last 12 months
Results
Revenue
$26.3B
+7.9% vs a year ago
Net income
$3.6B
+23.1% vs a year ago
EPS (diluted)
$9.39
+23.4% vs a year ago
Free cash flow
$4.6B
17.4% margin
Valuation
Market cap
$118B
380.7M shares
P/E
33.0
Price over 12 month EPS
Price to sales
4.5
Market cap over revenue
Dividend yield
1.14%
$3.52 a share over 12 months
Balance sheet
Cash & equivalents
$3.3B
At Sep 30
Debt
$14.9B
At Sep 30
Shares outstanding
380.7M
At Sep 30
CEOKevin A. Lobo
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $17.1B$17.1BFY2021FY2022: $18.4B$18.4BFY2022FY2023: $20.5B$20.5BFY2023FY2024: $22.6B$22.6BFY2024FY2025: $25.1B$25.1BFY2025

From SYK's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 30). Last 12 months adds up the four latest quarters.

Next report
Jan 28
Estimated date · After the close
Reported EPS
$1.96
Quarter ended Sep 2026
Year ago EPS
$2.22
−11.7% on a GAAP basis
Revenue
$6.52B
+7.6% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $1.41Dec '24Mar 2025: $1.69Mar '25Jun 2025: $2.29Jun '25Sep 2025: $2.22Sep '25Dec 2025: $2.20Dec '25Mar 2026: $1.93Mar '26Jun 2026: $3.30Jun '26Sep 2026: $1.96Sep '26Latest $1.96
Revenue by quarter
Dec 2024: $6.44BDec '24Mar 2025: $5.87BMar '25Jun 2025: $6.02BJun '25Sep 2025: $6.06BSep '25Dec 2025: $7.17BDec '25Mar 2026: $6.02BMar '26Jun 2026: $6.59BJun '26Sep 2026: $6.52BSep '26Latest $6.52B
How SYK moved after its last 8 reports
Average move the session after a report ±4.1%
Oct 29, 2026After the close−6.4%
Jul 30, 2026After the close−6.4%
Apr 30, 2026After the close−6.5%
Jan 29, 2026After the close+4.3%
Oct 30, 2025After the close−3.5%
Jul 31, 2025After the close−3.8%
May 1, 2025After the close+1.1%
Jan 28, 2025After the close−1.0%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on SYKStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on SYK
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on SYK

Technical Analysis

SYK · as of the Nov 20 close · updated each morning
Bounce inside a longer downtrend

The stock sits between its 20 and 50 day averages. It is 3% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 50). The nearest support is the swing low (Jul 2) at $307.49, and the nearest resistance the 100 day average at $310.33.

Short trendBullish
Long trendBearish
MomentumFading
StretchNormal
VolatilityHigh, 3.4%/day
Key levels
$389.3352 week high+25.6%
$320.67200 day average+3.4%
$317.71Pivot R1+2.5%
$314.6720 day average+1.5%
$313.26Pivot+1.1%
$312.80Swing high (Oct 29)+0.9%
$310.33100 day average+0.1%
$310.00Last close
$307.49Swing low (Jul 2)−0.8%
$305.56Pivot S1−1.4%
$295.6350 day average−4.6%
$267.0052 week low−13.9%
Indicators
RSI (14)50.08Middle of its rangeNeutral
MACD4.28Below its signal lineBearish
Stochastic32.4Middle of its rangeNeutral
ADX (14)14.4No clear trend
Williams %R-91.7Oversold below −80, overbought above −20Oversold
CCI (20)-8.4Oversold below −100, overbought above 100Neutral
Rate of change−4.9%Change over 10 sessionsBearish
ATR (14)$10.51Typical daily range, 3.4% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Below
MA 200Below
What happened before, for SYK

What happened before

See how SYK did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow SYK usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How SYK has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for SYKHow many large options trades hit SYK, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

SYK Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bearish
Strongly bearishNeutralStrongly bullish
  • ▼904 buying vs 1,141 selling
  • ▼Held by funds -2.2 pts
  • ▼Funds holding -93
  • ▼Superinvestors: 1 added, 4 cut
  • ▲Put/call 0.70 to 0.59
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding2,1782,271−4.1%
In funds' top 103537−5.4%
Held by funds78.8%81.0%−2.2 pts
New / increased135 / 769139 / 913−14.1%
Reduced / sold out934 / 207856 / 182+9.9%
Put/call ratio0.590.70−15.3%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See SYK institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

SYK Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$579.7M10 sales · 7 insiders
2026-02 sold $181.9M2026-05 sold $100.7M2026-08 sold $118.2M2026-11 sold $178.9MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 6Ronda E StrykerDirectorSale550,000$325.32$178.9M
Aug 21Dylan Bram CrottyGroup PresidentSale441$328.61$145K
Aug 19Ronda E StrykerDirectorSale350,000$336.50$117.8M
Aug 18Debra KingSee RemarksSale826$336.30$278K
May 28Robert S FletcherVP, Chief Legal OfficerSale plan4,544$306.87$1.4M
May 26Ronda E StrykerDirectorSale310,000$312.23$96.8M
Every insider buy and sale for SYK over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See SYK insider trades →

From SEC Form 4 filings by SYK's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

SYK Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
—
 
Left in program
$33.0M
0.0% of value
Shares outstanding, 12 months
−0.5%
Fewer shares
Last quarter
$1.0B
Sep 2026
Avg price paid, last quarter
$334.27
3.0M shares bought
S&P 500 rank by spending
—
 
Spent each quarter, last 3 yearsTop bar $1.0B
Dec 2023: $0Mar 2024: $0Jun 2024: $0Sep 2024: $0Dec 2024: $0Mar 2025: $0Jun 2025: $0Sep 2025: $0Dec 2025: $0Mar 2026: $0Jun 2026: $0Sep 2026: $1.0B, average price $334.27
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Oct 30, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SYK is in one of them and how their past SYK trades turned out.

SYK in the AI portfolios
Loading…

SYK News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered SYK in an article yet. Here's the latest on the wider market.

SYK in the news

SYK Congress Trades

All congress trades →
Trades, 12 months
16
Buys
5
31%
Sells
11
69%
People
5
Last filed Nov 19
Who traded SYK · since 2014
Latest 5 filings of 99
Thomas KeanSell (partial)
$1K – $15KTraded Oct 27, 2026Filed Nov 19, 2026
$1K – $15KTraded Oct 13, 2026Filed Nov 5, 2026
$1K – $15KTraded Oct 7, 2026Filed Nov 5, 2026
Thomas KeanSell (partial)
$1K – $15KTraded Sep 30, 2026Filed Oct 30, 2026
$1K – $15KTraded Sep 25, 2026Filed Oct 7, 2026
PersonTypeAmountTradedFiledDelay
Thomas KeanR · NJSell (partial)$1K – $15KOct 27, 2026Nov 19, 202623 d
Ro KhannaD · CABuy$1K – $15KOct 13, 2026Nov 5, 202623 d
Ro KhannaD · CASell$1K – $15KOct 7, 2026Nov 5, 202629 d
Thomas KeanR · NJSell (partial)$1K – $15KSep 30, 2026Oct 30, 202630 d
Ro KhannaD · CASell$1K – $15KSep 25, 2026Oct 7, 202612 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Stryker

Stryker makes medical technology used in surgery, emergency care and patient care. Its products include surgical equipment and navigation systems, endoscopy and communications systems, patient handling and emergency medical equipment, and implants for hip, knee and shoulder joint replacement. It also sells treatments for stroke and blood clots, along with the Mako robotic-arm system used in orthopaedic surgery. Most products are sold directly to doctors, hospitals and other healthcare facilities. The company is based in Portage, Michigan.

Headquarters
Portage, MI
Founded
1946